Spectrum Pharmaceuticals Inc.

09/13/2021 | Press release | Distributed by Public on 09/13/2021 05:07

Spectrum Pharmaceuticals Announces Late-Breaking Oral Presentation of Data for Poziotinib in First-Line NSCLC Patients with HER2 Exon 20 Mutations at the Upcoming ESMO Congress[...]